title: The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins.
abstract: Purified human cholesteryl ester transfer protein (CETP) has been found, under certain conditions, to promote changes to the particle size distribution of high-density lipoproteins (HDL) which are comparable to those attributed to a putative HDL conversion factor. When preparations of either the conversion factor or CETP are incubated with HDL3 in the presence of very-low-density lipoproteins (VLDL) or low-density lipoproteins (LDL), the HDL3 are converted to very small particles. The possibility that the conversion factor may be identical to CETP was supported by two observations: (1) CETP was found to be the main protein constituent of preparations of the conversion factor and (2) an antibody to CETP not only abolished the cholesteryl ester transfer activity of the conversion factor preparations but also inhibited changes to HDL particle size. In additional studies, the changes to HDL particle size promoted by purified CETP were inhibited by the presence of fatty-acid-free bovine serum albumin; by contrast, albumin had no effect on the cholesteryl ester transfer activity of the CETP. The possibility that albumin may inhibit changes to HDL particle size by removing unesterified fatty acids from either the lipoproteins or CETP was tested by adding exogenous unesterified fatty acids to the incubations. In incubations of HDL with either VLDL or LDL, sodium oleate had no effect on HDL particle size. However, when CETP was also present in the incubation mixtures the capacity of CETP to reduce the particle size of HDL was greatly enhanced by the addition of sodium oleate. It is concluded that the changes in HDL particle size which were previously attributed to an HDL conversion factor can be explained in terms of the interacting effects of CETP and unesterified fatty acids.
authors.affiliation: Baker Medical Research Institute, Melbourne, Australia.
authors.forename: P J
authors.initials: PJ
authors.lastname: Barter
authors.forename: L B
authors.initials: LB
authors.lastname: Chang
authors.forename: H H
authors.initials: HH
authors.lastname: Newnham
authors.forename: K A
authors.initials: KA
authors.lastname: Rye
authors.forename: O V
authors.initials: OV
authors.lastname: Rajaram
mesh_terms: D000328:Adult; D001053:Apolipoproteins / Q000097:blood; D002352:Carrier Proteins / Q000097:blood*; D053480:Cholesterol Ester Transfer Proteins; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D006023:Glycoproteins; D006801:Humans; D007074:Immunoglobulin G; D008075:Lipoproteins, HDL / Q000097:blood* / Q000302:isolation & purification; D008297:Male; D019301:Oleic Acid; D009829:Oleic Acids / Q000378:metabolism; D011487:Protein Conformation
chemical_list: D001053:Apolipoproteins; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D005230:Fatty Acids, Nonesterified; D006023:Glycoproteins; D007074:Immunoglobulin G; D008075:Lipoproteins, HDL; D009829:Oleic Acids; D019301:Oleic Acid